HealthCholesterol Drug Repatha Slashes Heart Attack Risk By 27 Percent But Disappoints Doctors And Investors Amgen's cholesterol-reducing drug Repatha reduced heart attack rate by 27 percent and stroke by 21 percent. Why are doctors and investors disappointed at the results of the drug's clinical trial?by Allan Adamson
HealthToo Much Meat, Salt And Not Enough Nuts Linked To Deaths From Diabetes, Stroke, And Heart Diseaseby Vincent Lanaria
HealthProtein Inhibitor Drug Shows Promise Preventing Artery Disease In High-Risk Individualsby Saranya Palanisamy
HealthSmart Skin Patch Developed To Release Blood Thinners As Needed, Prevent Dangerous Blood Clotsby Saranya Palanisamy
HealthBrain Implant Helps Paralyzed ALS Patient Communicate With Caregivers Without Assistanceby Rhodi Lee